Cargando…

Prevalence and factors associated with ongoing transmission of Schistosoma haematobium after 12 rounds of Praziquantel Mass Drug Administration among school age children in Southern Tanzania

BACKGROUND: World Health Organization (WHO) recommends periodic praziquantel Mass Drug Administration (MDA) to vulnerable populations, especially school-aged children, to reduce the risk of transmission. In the S. haematobium endemic Lindi region, on the southeastern coast of Tanzania, praziquantel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malibiche, Ditrick, Mushi, Vivian, Justine, Nyanda C., Silvestri, Valeria, Mhamilawa, Lwidiko E., Tarimo, Donath
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Research article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485624/ https://www.ncbi.nlm.nih.gov/pubmed/37692460 http://dx.doi.org/10.1016/j.parepi.2023.e00323

Ejemplares similares

Persistence of Schistosoma haematobium transmission among school children and its implication for the control of urogenital schistosomiasis in Lindi, Tanzania
por: Mushi, Vivian, et al.
Publicado: (2022)

Burden and factors associated with ongoing transmission of soil-transmitted helminths infections among the adult population: A community-based cross-sectional survey in Muleba district, Tanzania
por: Zacharia, Franco, et al.
Publicado: (2023)

Burden and risk factors for Schistosoma mansoni infection among primary school children: A quantitative school-based cross-sectional survey in Busega district, Northern Tanzania
por: Ogweno, George, et al.
Publicado: (2023)

Praziquantel, Mefloquine-Praziquantel, and Mefloquine-Artesunate-Praziquantel against Schistosoma haematobium: A Randomized, Exploratory, Open-Label Trial
por: Keiser, Jennifer, et al.
Publicado: (2014)

Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya.
por: King, C H, et al.
Publicado: (2000)

Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya.
por: Coles, G C, et al.
Publicado: (2001)

Efficacy of Praziquantel against Schistosoma haematobium in Dulshatalo village, western Ethiopia
por: Mekonnen, Asaye, et al.
Publicado: (2013)

Efficacy of Artesunate + Sulfamethoxypyrazine/Pyrimethamine versus Praziquantel in the Treatment of Schistosoma haematobium in Children
por: Sissoko, Mahamadou S., et al.
Publicado: (2009)

Efficacy and safety of praziquantel against Schistosoma haematobium in the Ikata-Likoko area of southwest Cameroon
por: Ebai, Calvin Bisong, et al.
Publicado: (2017)

Organomegaly in Mali before and after praziquantel treatment. A possible association with Schistosoma haematobium
por: Stecher, Chalotte Willemann, et al.
Publicado: (2017)

In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium
por: Kovač, Jana, et al.
Publicado: (2017)

Schistosoma haematobium infections among schoolchildren in central Sudan one year after treatment with praziquantel
por: Ahmed, Abedaziz M, et al.
Publicado: (2012)

Efficacy and Safety of Praziquantel in Preschool-Aged Children in an Area Co-Endemic for Schistosoma mansoni and S. haematobium
por: Coulibaly, Jean T., et al.
Publicado: (2012)

A Praziquantel Treatment Study of Immune and Transcriptome Profiles in Schistosoma haematobium-Infected Gabonese Schoolchildren
por: Labuda, Lucja A, et al.
Publicado: (2019)

Schistosoma haematobium infection and environmental factors in Southwestern Tanzania: A cross-sectional, population-based study
por: Manz, Kirsi M., et al.
Publicado: (2020)

Schistosoma haematobium
por: Corsini Campioli, Cristina, et al.
Publicado: (2022)

Adolescents and young adults excluded from preventive chemotherapy for schistosomiasis control in Northern Tanzania: are they at risk and reservoirs of infection? Prevalence and determinants of transmission in Northern Tanzania
por: Maseke, Leah S., et al.
Publicado: (2022)

Schistosoma haematobium Treatment in 1–5 Year Old Children: Safety and Efficacy of the Antihelminthic Drug Praziquantel
por: Mutapi, Francisca, et al.
Publicado: (2011)

Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies
por: RUJENI, N, et al.
Publicado: (2012)

Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya
por: Kimani, Bridget W., et al.
Publicado: (2018)

Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
por: Dejon-Agobé, Jean Claude, et al.
Publicado: (2019)

Case Series of Adenocarcinoma of the Prostate Associated with Schistosoma haematobium Infection in Tanzania
por: Mazigo, Humphrey D, et al.
Publicado: (2010)

Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial
por: Barda, Beatrice, et al.
Publicado: (2016)

Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children
por: Stete, Katarina, et al.
Publicado: (2012)

Efficacy of praziquantel in the treatment of Schistosoma haematobium infection among school-age children in rural communities of Abeokuta, Nigeria
por: Ojurongbe, Olusola, et al.
Publicado: (2014)

Impact of Single Dose Praziquantel Treatment on Schistosoma haematobium Infection among School Children in an Endemic Nigerian Community
por: Adewale, Babatunde, et al.
Publicado: (2018)

Correction to: Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
por: Dejon-Agobé, Jean Claude, et al.
Publicado: (2021)

Prevalence and risk factors of urogenital schistosomiasis among under-fives in Mtama District in the Lindi region of Tanzania
por: Mushi, Vivian, et al.
Publicado: (2022)

Three monthly doses of 60 mg/kg praziquantel for Schistosoma haematobium infection is a safe and effective treatment regimen
por: Darko, Samuel Nkansah, et al.
Publicado: (2020)

Intestinal schistosomiasis among secondary school students in Northern Tanzania: prevalence, infection intensity and associated risk factors
por: Samweli, Lilian G, et al.
Publicado: (2022)

Burden and factors associated with onchocerciasis transmission among school-aged children after more than 20 years of Community Directed Treatment with Ivermectin in Ulanga district, Tanzania: A school-based cross-sectional study
por: Mshana, Mwanahawa I., et al.
Publicado: (2023)

Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration
por: Crellen, Thomas, et al.
Publicado: (2016)

Efficacy and Safety of Praziquantel for Treatment of Schistosoma mansoni Infection among School Children in Tanzania
por: Mnkugwe, Rajabu Hussein, et al.
Publicado: (2019)

Prevalence and intensity of Schistosoma haematobium infection among schoolchildren in central Zambia before and after mass treatment with a single dose of praziquantel
por: Shehata, Mohamed A., et al.
Publicado: (2018)

Dynamics in Morbidity Markers and Cytological Observations Made in Urine of Schistosoma haematobium-Infected Children: Pre- and Post-Praziquantel Treatment in an Endemic Setting
por: Tetteh-Quarcoo, Patience B., et al.
Publicado: (2022)

Schistosoma haematobium Infection and Buruli Ulcer
por: Scott, Janet T., et al.
Publicado: (2004)

CRISPR-assisted test for Schistosoma haematobium
por: Cherkaoui, Dounia, et al.
Publicado: (2023)

Population genetic structure of Schistosoma haematobium and Schistosoma haematobium × Schistosoma bovis hybrids among school-aged children in Côte d’Ivoire
por: Angora, Etienne K., et al.
Publicado: (2022)

Diagnostic Performance of Schistosoma Real-Time PCR in Urine Samples from Kenyan Children Infected with Schistosoma haematobium: Day-to-day Variation and Follow-up after Praziquantel Treatment
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2014)

Electrocardiographic safety evaluation of extended artemether-lumefantrine treatment in patients with uncomplicated Plasmodium falciparum malaria in Bagamoyo District, Tanzania
por: Mhamilawa, Lwidiko E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rilcbdk38i9o6on85kbe6lt5jl